Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal
Reexamination Certificate
2007-07-24
2007-07-24
Wehbe, Anne Maria S. (Department: 1633)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
Transgenic nonhuman animal
C800S003000
Reexamination Certificate
active
11038387
ABSTRACT:
A mouse that is deficient for c-Jun and JunB in the epidermis or in which deletion of c-Jun and JunB can be specifically induced in the epidermis, and methods for obtaining such mice. The mice and keratinocytes derived therefrom are useful as an animal model for psoriasis and psoriatic arthritis.
REFERENCES:
patent: WO 96/27019 (1996-09-01), None
patent: WO 00/12754 (2000-03-01), None
patent: WO 00/72666 (2000-12-01), None
patent: WO 01/22090 (2001-03-01), None
patent: WO 02/062135 (2002-08-01), None
Szabowski et al. Cell 103:745-755, 2000; of record.
Li et al. Developmental Cell 4:865-877, 2003; of record.
Vasioukhin et al. PNAS 96:8551-8556, 1999; of record.
Zenz et al. Nature 437: 369-375; 2005.
Baichwal, V.R., and Tjian, R., “Control of c-Jun Activity by Interaction of a Cell-Specific Inhibitor with Regulatory Domain δ: Differences between v- and c-Jun,”Cell 63:815-825, Cell Press (1990).
Behrens, A., et al., “Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-junin the liver,”EMBO J. 21:1782-1790, Oxford University Press (2002).
Bohmann, D., and Tjian, R., “Biochemical Analysis of Transcriptional Activation by Jun: Differential Activity of c- and v-Jun,”Cell 59: 709-717, Cell Press (1989).
Boyle, W.J., et al., “Activation of Protein Kinase C Decreases Phosphorylation of c-Jun at Sites That Negatively Regulate Its DNA-Binding Activity,”Cell 64: 573-584, Cell Press (1991).
Branda, C.S., and Dymecki, S.M., “Talking about a Revolution: The Impact of Site-Specific Recombinases on Genetic Analyses in Mice,”Dev. Cell 6:7-28, Cell Press (Jan. 2004).
Brocard, J., et al., “Spatio-temporally controlled site-specific somatic mutagenesis in the mouse,”Proc. Natl. Acad. Sci. USA 94:14559-14563, National Academy of Sciences (1997).
Carroll, J.M., and Molés, J-P., “A three-dimensional skin culture model for mouse keratinocytes: application to transgenic mouse keratinocytes,”Exp. Dermatol. 9:20-24, Munskgaard (2000).
Carroll, J.M., et al., “Suprabasal Integrin Expression in the Epidermis of Transgenic Mice Results in Developmental Defects and a Phenotype Resembling Psoriasis,”Cell 83: 957-968, Cell Press (1995).
Chiu, R., et al., “Jun-B Differs in Its Biological Properties from, and Is a Negative Regulator of, c-Jun,”Cell 59:979-986, Cell Press (1989).
Danielian, P.S., et al., “Identification of Residues in the Estrogen Receptor That Confer Differential Sensitivity to Estrogen and Hydroxytamoxifen,”Mol. Endocrinol. 7:232-240, Endocrine Society (1993).
Deng, T., and Karin, M., “JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers,”Genes Dev. 7:479-490, Cold Spring Harbor Laboratory Press (1993).
Du, W., et al., “Mechanims of Transcriptional Synergism between Distinct Virus-Inducible Enhancer Elements,”Cell 74: 887-898, Cell Press (1993).
Eferl, R., and Wagner, E.F., “AP-1: A Double-Edged Sword in Tumorigenesis,”Nat. Rev. Cancer 3:859-868, Nature Publishing Group (Nov. 2003).
Herrlich, P., and Ponta, H., “Nuclear' Oncogenes Convert Extracellular Stimuli into Changes in the Genetic Program,”Trends Genet. 5:112-116, Elsevier Science Publisher Ltd. (1989).
Hilberg, F., et al., “c-Jun is essential for normal mouse development and hepatogenesis,”Nature 365: 179-181, Macmillan Magazines Ltd. (1993).
Imler, J.L., et al., “v-jun is a transcriptional activator, but not in all cell-lines,”Nucleic Acids Res. 16:3005-3012, IRL Press Ltd. (1988).
Jiang, C-K., et al., “Functional Comparison of the Upstream Regulatory DNA Sequences of Four Human Epidermal Keratin Genes,”J. Invest. Dermatol. 96:162-167, Elsevier Science Publishing Co., Inc. (1991).
Johnson, R.S., et al., “A null mutation at the c-junlocus causes embryonic lethality and retarded cell growth in culture,”Genes Dev. 7:1309-1317, Cold Spring Harbor Laboratory Press (1993).
Karin, M., and Smeal, T., “Control of transcription factors by signaling transduction pathways: the beginning of the end,”Trends. Biochem. Sci. 17:418-422 Elsevier Science Publishers (1992).
Kenner, L., et al., “Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects,”J. Cell Biol. 164:613-623, Rockefeller University Press (Feb. 2004).
Kunath, T., et al., “Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype,”Nat. Biotechnol. 21:559-561, Nature Publishing Group (May 2003).
Lebwohl, M., “Psoriasis,”Lancet 361:1197-1204, Lancet Publishing Group (Apr. 2003).
Li, B., et al., “Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation,”EMBO J. 18:420-432, Oxford University Press (1999).
Li, G., et al., “c-Jun Is Essential for Organization of the Epidermal Leading Edge,”Dev. Cell 4:865-877, Cell Press (Jun. 2003).
Lin, A., et al., “Casein Kinase II is a Negative Regulator of c-Jun DNA Binding and AP-1 Activity,”Cell 70:777-789, Cell Press (1992).
Minamino, T., et al., “Inducible Gene Targeting in Postnatal Myocardium by Cardiac-Specific Expression of a Hormone-Activated Cre Fusion Protein,”Circ Res. 88:587-592, Lippincott Williams & Wilkins (2001).
Nickoloff, B.J., et al., “Is psoriasis a T-cell disease?”Exp. Dermatol. 9: 359-375, Munksgaard (2000).
Pulverer, B.J., et al., “Phosphorylation of c-junmediated by MAP kinases,”Nature 353:670-674, Macmillan Magazines Ltd. (1991).
Ransone, L.J., and Verma, I.M., “Nuclear Proto-OncogenesFosandJun,” Annu. Rev. Cell Biol. 6:539-557, Annual Reviews, Inc. (1990).
Sachsenmaier, C., and Radler-Pohl, A., “Regulation of c-Jun Activity by Phosphorylation,” inThe FOS and JUN Families of Transcription Factors, Angel, P.E., and Herrlich, P.A., eds., CRC Press Inc., Boca Raton, FL, pp. 61-70 (1994).
Schön, M.P., “Animal Models of Psoriasis—What Can We Learn from Them?”J. Invest. Dermatol. 112:405-410, Blackwell Science (1999).
Schorpp-Kistner, M., et al., “JunB is essential for mammalian placentation,”EMBO J. 18:934-948, Oxford University Press (1999).
Stein, B., et al., “Cross-coupling of the NF-κB p. 65 and Fos/Jun transcription factors produces potentiated biological function,”EMBO J. 12:3879-3891, Oxford University Press (1993).
Szabowski, A., et al., “c-Jun and JunB Antagonistically Control Cytokine-Regulated Mesenchymal-Epidermal Interaction in Skin,”Cell 103:745-755, Cell Press (2000).
Vasioukhin, V., et al., “The magical touch: Genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin,”Proc. Natl. Acad. Sci. USA 96:8551-8556, National Academy of Sciences (1999).
Xia, H., et al., “siRNA-mediated gene silencing in vitro and in vivo,”Nat. Biotechnol. 20:1006-1010, Nature Publishing Group (2002).
Xia, Y-P., et al., “Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis,”Blood 102:161-168, American Society of Hematology (Jul. 2003).
Zenz, R., et al., “c-Jun Regulates Eyelid Closure and Skin Tumor Development through EGFR Signaling,”Dev. Cell 4:879-889, Cell Press (Jun. 2003).
International Search Report for International Application No. PCT/EP2005/000517, European Patent Office, Netherlands, mailed on Jun. 2, 2005.
Angel, P., et al., “Function and regulation of AP-1 subunits in skin physiology and pathology,”Oncogene 20: 2413-2423, Nature Publishing Group (2001).
Angel, P. amd Herrlich, P., “General Structure of AP-1 Subunits and Characteristics of the Jun Proteins,” inThe fos and jun families of transcription factor, CRC Press, Inc., pp. 3-14 (1994).
Werner, S. and S
Wagner Erwin
Zenz Rainer
Boehringer Ingelheim International GmbH
Sajjadi Fereydoun G.
Sterne Kessler Goldstein & Fox P.L.L.C.
Wehbe Anne Maria S.
LandOfFree
Mouse model for psoriasis and psoriatic arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mouse model for psoriasis and psoriatic arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mouse model for psoriasis and psoriatic arthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3800784